Top compounds associated with response to LRRC9


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA pac-1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Topotecan CTRPv2 pan-cancer AAC 0.099 0.002
mRNA CD-437 CTRPv2 pan-cancer AAC 0.1 0.002
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC 0.14 0.002
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.093 0.003
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.12 0.003
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.096 0.003
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.003
Download CSV